SLC12A1 and nonpapillary renal cell carcinoma: SLC12A1 shows a protective effect, as hypomethylation at CpG sites cg07915221 and cg14930674 is associated with hazard ratios of 0.442 and 0.422, which suggest a reduced risk of ccRCC.